Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids.
about
A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymeActive-site-directed inactivators of the Zn2+-containing D-alanyl-D-alanine-cleaving carboxypeptidase of Streptomyces albus GSerum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I moleculesNatural Inhibitors of Snake Venom Metalloendopeptidases: History and Current ChallengesIncreasing the structural coverage of tuberculosis drug targetsStructural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captoprilCrystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzymeInteraction of angiotensin I-converting enzyme with two potent tricyclic inhibitorsInhibitors of angiotensin-converting enzyme containing a tetrahedral arsenic atomIonization states of the complex formed between 2-benzyl-3-phosphonopropionic acid and carboxypeptidase AEffect of angiotensin-converting enzyme inhibitor YS980 on prostaglandin synthesis in rabbit kidney medulla slicesAcute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker ratMixed-type inhibition of pulmonary angiotensin I-converting enzyme by captopril, enalaprilat and ramiprilatThe toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiaeNovel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease.Protein crystallography and infectious diseases.Kinetic investigation of the specificity of porcine brain thyrotropin-releasing hormone-degrading ectoenzyme for thyrotropin-releasing hormone-like peptides.Data in support of optimized production of angiotensin-I converting enzyme inhibitory peptides derived from proteolytic hydrolysate of bitter melon seed proteins.Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data.Cloning and nucleotide sequence of the Salmonella typhimurium dcp gene encoding dipeptidyl carboxypeptidaseAngiotensin converting enzyme inhibitors as potential cognitive enhancing agents.Metal-coordinating substrate analogs as inhibitors of metalloenzymesACE for all - a molecular perspectivedcp gene of Escherichia coli: cloning, sequencing, transcript mapping, and characterization of the gene product.Control of essential hypertension with captopril, an angiotensin converting enzyme inhibitor.Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity.Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling.Combining renin-angiotensin-aldosterone system blockade with diuretic therapy for treatment of hypertension.The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesisInhibitor and substrate binding by angiotensin-converting enzyme: quantum mechanical/molecular mechanical molecular dynamics studies.The carboxypeptidase ACE shapes the MHC class I peptide repertoireAutoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain.Digestion and assimilation of proline-containing peptides by rat intestinal brush border membrane carboxypeptidases. Role of the combined action of angiotensin-converting enzyme and carboxypeptidase P.Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.Conversion of angiotensin I to angiotensin II in the human foetoplacental vascular bedSerine protease inhibition by a silanediol peptidomimetic.Phosphorus-containing inhibitors of angiotensin-converting enzymeSpecific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.A Tricholoma matsutake Peptide with Angiotensin Converting Enzyme Inhibitory and Antioxidative Activities and Antihypertensive Effects in Spontaneously Hypertensive Rats.Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection.
P2860
Q24306614-29DDDA6D-2D12-4CC3-AF09-F60C5B1D515FQ24529946-161F3547-CFB1-480C-9330-916DC0B01CEBQ24675294-7CE01FB1-6A7A-41D6-A850-964B6784866BQ26738414-A0DFB051-931F-4435-B03E-5A3531AA0E07Q27644314-3CC591CC-95EB-423A-890B-852A078C48B7Q27671388-A635DB70-B31E-4191-8C79-7E108F7D87E0Q27680712-0CAF6F07-CE69-4C02-9D65-23970E52CB7DQ28342588-181BEAA3-E16B-4EEA-88D5-2ACC03981E36Q28360272-82FA7768-946F-4D10-87A5-0EC04E34086EQ28361174-29DFB38C-DC04-4EA9-A0C0-02D76EF7265FQ28361641-D30CC29E-D769-456D-89FC-34C7DCE29363Q28366562-8725EF1F-FE15-4865-AC67-345713139621Q28610111-484EB763-18BC-409E-B47C-C271DF5C04E7Q29198329-9DBD92A6-260F-426A-838A-2F286D96A05AQ30235583-864C44BB-A5DD-425D-AFD5-834B26C9B641Q30419162-E4B2AB4A-190D-41AA-A5B4-DA7F05FED3B6Q30854416-E9D0EE98-F1BF-41FF-83DE-57FABAE829F4Q31055372-E04EBBD7-4A4B-458B-835C-899442AE8D8BQ31102886-25EF507B-1756-4ABB-9B50-2583718FA90EQ33206963-C0F83947-9EB2-4B30-8DD6-8AE8B9066CB9Q33921329-815004DF-83B4-4324-8840-A20BB001A63AQ33986513-099420EE-5500-4CF5-807C-8C00AB8E14E4Q34195870-AC5E9F72-3D8E-4FAC-BFBB-484607DF959BQ34343766-555FB554-0190-43C3-99F5-8B06F602368BQ34448560-8E005634-D0CB-4E85-AB8B-EEB77305D6DEQ34500424-0A19ACE3-3C37-4974-91AB-C003349C9FF1Q34512406-9289D246-AE06-4311-B94A-15794CBEE990Q34849510-42C33185-CA07-4078-88A4-F7F43927B61CQ35050809-12E9E03A-CBFD-44D4-A3A7-DC684AFAD21DQ35167293-1622EA95-F38A-4537-89C6-FE68B3B3C522Q35402189-34E94837-C64D-409B-AB7D-2B1AD7655B28Q35593778-466A9943-3E7B-4E61-9477-2F2109F204B2Q35811130-215D3426-7C19-4D53-8F26-E6EB6FB5D978Q35913360-0CC8B4A7-421B-4667-A86F-B77AB2419D14Q36004312-CCBBBC58-C675-4183-AF66-3ACDF522E0AAQ36218661-FD1DD067-4035-4AE7-8764-A9EFF91C3B81Q36289138-BF3A9E5E-4252-4DDD-8D92-1BD171D7E75DQ36407178-5C2E6CAB-319C-4CE1-8A0E-33B98CACF883Q36774443-6C7DB734-7623-43E5-909F-C0DE652483F1Q36799869-76DF6C5E-0696-4C2B-9841-48386037A6AD
P2860
Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids.
description
1977 nî lūn-bûn
@nan
1977 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Design of potent competitive i ...... mercaptoalkanoyl amino acids.
@ast
Design of potent competitive i ...... mercaptoalkanoyl amino acids.
@en
Design of potent competitive i ...... mercaptoalkanoyl amino acids.
@nl
type
label
Design of potent competitive i ...... mercaptoalkanoyl amino acids.
@ast
Design of potent competitive i ...... mercaptoalkanoyl amino acids.
@en
Design of potent competitive i ...... mercaptoalkanoyl amino acids.
@nl
prefLabel
Design of potent competitive i ...... mercaptoalkanoyl amino acids.
@ast
Design of potent competitive i ...... mercaptoalkanoyl amino acids.
@en
Design of potent competitive i ...... mercaptoalkanoyl amino acids.
@nl
P2093
P356
P1433
P1476
Design of potent competitive i ...... mercaptoalkanoyl amino acids.
@en
P2093
P304
P356
10.1021/BI00644A014
P407
P577
1977-12-01T00:00:00Z